Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2006; 12(15): 2351-2356
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2351
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2351
Table 1 Baseline characteristics in different study groups (mean±SD)
| Groups | n | Body weight | Mean arterial | Heart rate |
| ( g ) | pressure(mmHg) | (beat/min) | ||
| Vehicle | 8 | 326.7 ± 10.6 | 98.6 ± 3.6 | 296 ± 18 |
| Verapamil | 8 | 332.6 ± 11.8 | 96.5 ± 4.8 | 320 ± 16 |
| Verapamil+vehicle | 8 | 321.5 ± 9.8 | 99.5 ± 5.2 | 318 ± 20 |
| Verapamil+NNA | 8 | 330.8 ± 9.6 | 97.4 ± 3.8 | 317 ± 17 |
| Verapamil+INDO | 7 | 327.8 ± 8.5 | 94.2 ± 6.2 | 328 ± 14 |
| Verapamil+ INDO+NNA | 8 | 319.8 ± 7.9 | 96.2 ± 4.8 | 308 ± 15 |
- Citation: Lay CS, May C, Lee FY, Tsai YT, Lee SD, Chien S, Sinchon S. Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: Role of prostaglandin. World J Gastroenterol 2006; 12(15): 2351-2356
- URL: https://www.wjgnet.com/1007-9327/full/v12/i15/2351.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i15.2351